H2020FP7HORIZON
Ospedale Pediatrico Bambino Gesu
- Country
- ITItaly
- Projects
- 59
- As coordinator
- 2
- EU contribution (CORDIS)
- EUR 19,950,388
- Active
- 2008 to 2024
Projects
59 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| LEAFLEAF: heaL thE plAnet's Future | HORIZON | 2024 | Associated partner | EUR 0 |
| GALATEAdiGitAL twin frAmework for TailorEd infAnt nutrition | HORIZON | 2024 | Participant | EUR 55,200 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 87,188 |
| DyphaDypha: adding the dimension of time to cell culture | HORIZON | 2024 | Participant | EUR 325,000 |
| Recon4IMDReconstruction and Computational Modelling for Inherited Metabolic Diseases | HORIZON | 2023 | Participant | EUR 10,000 |
| IntReALL 2020International Study for Treatment of Childhood Relapsed ALL 2020 | HORIZON | 2023 | Participant | EUR 1,133,939 |
| IMPACT- AMLMaster Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia | HORIZON | 2023 | Participant | EUR 442,500 |
| EChiLiBRiSTDevelopment and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival | HORIZON | 2022 | Participant | EUR 28,625 |
| CYLCOMEDCyber securitY tooLbox for COnnected MEdical Devices | HORIZON | 2022 | Participant | EUR 313,129 |
| LEAFLEAF: heaL thE plAnet's Future | HORIZON | 2022 | Associated partner | EUR 0 |
| SCREEN4CAREShortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies | H2020 | 2021 | Participant | EUR 753,848 |
| CAPSTONETraining experts in antigen processing to deliver new drug prototypes for cancer and autoimmune diseases | H2020 | 2021 | Participant | EUR 522,999 |
| AICCELERATEAI Accelerator – A Smart Hospital Care Pathway Engine | H2020 | 2021 | Participant | EUR 389,263 |
| T2EVOLVEAccelerating Development and Improving Access to CAR and TCR-engineered T cell therapy | H2020 | 2021 | Participant | EUR 560,600 |
| PharmaLedgerPharmaLedger | H2020 | 2020 | Participant | EUR 347,500 |
| INNERVATEInvestigating the functional impact of neurodegeneration-causing rare variants in the teleost model zebrafish | H2020 | 2020 | Coordinator | EUR 183,473 |
| PARENTPremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis | H2020 | 2020 | Participant | EUR 261,500 |
| INNODIA HARVESTTranslational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA | H2020 | 2020 | Participant | EUR 1,250 |
| B1MGBeyond 1M Genomes | H2020 | 2020 | Participant | EUR 56,250 |
| CIRCULAR VISIONCircular DNA in diagnosis and disease models | H2020 | 2020 | Participant | EUR 172,586 |
The country is the one the source records for the organisation’s registration (its PIC). A body with sites in several countries is recorded under one of them, which is not always its legal seat: the Spanish research council CSIC, for example, appears under Italy. The data holds no country per site, so we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.